当前位置: X-MOL 学术J. Antimicrob. Chemother. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bacterial population kinetics in heteroresistant Mycobacterium tuberculosis harbouring rare resistance-conferring mutations in gyrA and rpoB imply an epistatic interaction of mutations in a pre-XDR-TB patient
Journal of Antimicrobial Chemotherapy ( IF 3.9 ) Pub Date : 2020-04-17 , DOI: 10.1093/jac/dkaa109
Shiomi Yoshida 1 , Tomotada Iwamoto 2 , Kentaro Arikawa 2 , Tsuyoshi Sekizuka 3 , Makoto Kuroda 3 , Yoshikazu Inoue 1 , Satoshi Mitarai 4 , Taisuke Tsuji 5 , Kazunari Tsuyuguchi 1 , Katsuhiro Suzuki 6
Affiliation  

Bacterial population kinetics of strains harbouring drug resistance-conferring mutations within a patient often show cryptic resistance in clinical practice. We report a case that showed emergence and dominance of Mycobacterium tuberculosis with uncommon rpoB and gyrA mutations, followed by an rpoC compensatory mutation, during treatment.

中文翻译:

在细菌群体动力学heteroresistant结核杆菌窝藏在罕见的抗性突变的gyrA的rpoB意味着在预XDR-TB患者的突变的上位相互作用

在临床实践中,患者体内具有耐药性突变的菌株的细菌种群动力学常常显示出隐性耐药性。我们报告了一个案例,该案例显示在治疗过程中结核分枝杆菌的出现和优势与罕见的rpoBgyrA突变,然后是rpoC代偿性突变。
更新日期:2020-06-19
down
wechat
bug